| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6095750 | Gastroenterology | 2011 | 10 Pages |
Abstract
IL-22 appears to be an important mediator of the inflammatory response following recognition of HBV by T cells in the liver. These findings might be relevant to the development of cytokine-based therapies for patients with HBV infection.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Ye Zhang, Melissa A. Cobleigh, Jian-Qi Lian, Chang-Xing Huang, Carmen J. Booth, Xue-Fan Bai, Michael D. Robek,